Licensing-First Approach, Commercial-Ready Results
Today, Genvor partners with Tier-1 agricultural leaders and leverages a capital-efficient licensing model to bring its solutions to growers worldwide. Our peptide innovations are not just scientific advances—they’re real-world tools to meet the challenges of climate change, food security, and population growth.
Early partnerships with purpose
We’ve secured foundational alliances that support real-world testing, regulatory progress, and the path to commercialization.
USDA
Public-Sector Partnership Advancing Peptide Innovation
Genvor’s Cooperative Research and Development Agreement (CRADA) with the USDA targets aflatoxin-producing pathogens in corn, supporting the development of disease-resistant crops and advancing peptide commercialization across key markets.
Bayer
Bayer Awards Genvor the 2024 Golden Ticket
Genvor’s partnership with Bayer, through its Golden Ticket award, supports the advancement of peptide-based crop protection with access to lab space, technical mentorship, and commercialization pathways at LifeHub California @AgStart.
Let’s Grow the Future Together
Genvor is already in talks with 6+ top-tier ag industry leaders—our licensing-first model is built for real-world deployment and long-term success.
Interested in partnering? Let’s talk.
Email: licensing@genvor.com
Phone: (715)-903-6473